Publications by authors named "Kozo Oka"

Claim this Profile
M
MicroRNA-33 inhibition ameliorates muscular dystrophy by enhancing skeletal muscle regeneration.
Naoya Sowa, Takahiro Horie, Yuya Ide, Osamu Baba, Kengo Kora, Kozo Oka

EMBO Mol Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased neurotoxicity of high-density lipoprotein secreted from murine reactive astrocytes deficient in a peroxisomal very-long-chain fatty acid transporter Abcd1.
Naoki Fujitani, Tomoya Akashi, Masayoshi Saito, Masashi Morita, Takanori So, Kozo Oka

J Inherit Metab Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A monoclonal antibody activating AdipoR for type 2 diabetes and nonalcoholic steatohepatitis.
Naomi Asahara, Miki Okada-Iwabu, Masato Iwabu, Kouichi Wada, Kozo Oka

Sci Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis.
Sawa Miyagawa, Takahiro Horie, Tomohiro Nishino, Satoshi Koyama, Toshimitsu Watanabe, Kozo Oka

Life Sci Alliance· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Characteristic Phosphatidylcholine Containing Very Long Chain Fatty Acids in Cerebrospinal Fluid from Patients with X-Linked Adrenoleukodystrophy.
Naoki Fujitani, Masayoshi Saito, Tomoya Akashi, Masashi Morita, Takanori So, Kozo Oka

Biol Pharm Bull· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of microRNA-33b specifically ameliorates abdominal aortic aneurysm formation via suppression of inflammatory pathways.
Tomohiro Yamasaki, Takahiro Horie, Satoshi Koyama, Tetsushi Nakao, Osamu Baba, Kozo Oka

Sci Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients.
Naomichi Abe, Sayuka Kato, Takuma Tsuchida, Kanami Sugimoto, Ryuta Saito, Kozo Oka

Biol Open· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary iron restriction leads to a reduction in hepatic fibrosis in a rat model of non-alcoholic steatohepatitis.
Naomichi Abe, Takuma Tsuchida, Shin-Ichiro Yasuda, Kozo Oka

Biol Open· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of combined treatment with canagliflozin and teneligliptin on glucose intolerance in Zucker diabetic fatty rats.
Takahiro Oguma, Chiaki Kuriyama, Keiko Nakayama, Yasuaki Matsushita, Kumiko Yoshida, Kozo Oka

J Pharmacol Sci· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antioxidants suppress plasma levels of lectinlike oxidized low-density lipoprotein receptor-ligands and reduce atherosclerosis in watanabe heritable hyperlipidemic rabbits.
Kozo Oka, Mikiko Yasuhara, Kuniharu Suzumura, Keiko Tanaka, Tatsuya Sawamura

J Cardiovasc Pharmacol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis